On March 21, the three major A-share indexes rose for four consecutive trading days. As of the close, the Shanghai index rose 0.08% to 325369 points, the Shenzhen Composite Index rose 0.41% to 1237964 points, and the gem index rose 0.46% to 272618 points. Coal, agriculture, medicine and other sectors led the gains, while the large financial sector led the declines. More than 3200 stocks in the two cities rose, with a turnover of more than 1 trillion yuan and a net sale of 8.419 billion yuan from the north.
Most industry sectors rose, agricultural stocks performed prominently, and the subdivided planting industry was particularly strong, Jinjian Cereals Industry Co.Ltd(600127) , Heilongjiang Agriculture Company Limited(600598) , Xinjiang Talimu Agriculture Development Co.Ltd(600359) , etc. In terms of news, affected by the situation in Russia and Ukraine, global food security is facing severe challenges. According to the Shenzhen Agricultural Products Group Co.Ltd(000061) price report released by the food and Agriculture Organization of the United Nations, the prices of all major cereals in February increased compared with the previous month. World wheat prices rose by 2.1%, reflecting new global supply uncertainty.
NMN longevity drug concept stocks were active throughout the day, covid-19 special drug sector strengthened in the late trading, and led to the rise of pharmaceutical and biological sector. Nearly 30 stocks such as Chengda pharmaceutical, Tianjin Chase Sun Pharmaceutical Co.Ltd(300026) , Guangdong Zhongsheng Pharmaceutical Co.Ltd(002317) , Jinghua Pharmaceutical Group Co.Ltd(002349) , Shanghai Fosun Pharmaceutical (Group) Co.Ltd(600196) , etc. rose by more than 10%.
Recently, China Meheco Group Co.Ltd(600056) whose share price continued to soar again rose the limit and continued to hit a record high. The latest market value exceeded 39 billion yuan. The stock closed 11 daily limit in the last 14 trading days, with a cumulative rise of more than 230% in March.
China Meheco Group Co.Ltd(600056) signed an agreement with Pfizer on March 9, 2022. The company will be responsible for the commercial operation of Pfizer covid-19 virus treatment drug paxlovid in the Chinese market during the term of the agreement (2022). According to official WeChat official account of China Meheco Group Co.Ltd(600056) , in March 19th, the first batch of COVID-19 virus treatment drugs PAXLOVID, which was co operated by China Meheco Group Co.Ltd(600056) and Pfizer, has been transported to the Daxing logistics center of China Meheco Group Co.Ltd(600056) .
However, according to the dragon and tiger list on March 21, China Meheco Group Co.Ltd(600056) after a sharp rise in the early stage, institutions and hot money have begun to withdraw. The top five seats with the largest sales amount sold a total of 625 million yuan. Among them, 172 million yuan was sold in the special account of the institution located in the first place of sale; The securities business department of Citic Securities Company Limited(600030) Xi’an Zhuque street and Guotai Junan Securities Co.Ltd(601211) Shanghai branch located in the second and third selling positions sold 146 million yuan and 140 million yuan respectively.
The big financial sector led the decline, while the securities sector fell significantly Polaris Bay Group Co.Ltd(600155) fell by more than 6%, Guosheng Financial Holding Inc(002670) fell by more than 4%, Guolian Securities Co.Ltd(601456) , Shanghai Chinafortune Co.Ltd(600621) fell by more than 3%.
After the rebound, how will the A-share market interpret? From the point of view of many securities companies, with the clear policy signal, the stage similar to the sharp decline in the early stage may have ended.
China International Capital Corporation Limited(601995) said there was no need to be overly pessimistic about the future performance of a shares. Recently, the market may be in the bottom grinding period, and the trading volume may shrink. Although there are still repeated risks in the short term, the situation similar to the sharp decline in the early stage may have ended.
China Securities Co.Ltd(601066) securities also believes that with the clear policy signal, the panic has passed, superimposed with the improvement of the external environment and the easing of depreciation concerns, they are optimistic about the short-term market.
In terms of configuration, steady growth is still the main line favored by securities companies Haitong Securities Company Limited(600837) said that steady growth will be the main line of the pit filling market. The steady growth policy is expected to directly drive the growth of new and old infrastructure investment. Among them, the new infrastructure will be the balance point between short-term stable growth and medium – and long-term economic restructuring.
